Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Authors’ response: Association between IBD and Parkinson’s disease: seek and you shall find?

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Authors' response: Association between IBD and Parkinson's disease: seek and you shall find?

    Research output: Contribution to journalComment/debateResearch

  3. Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B

    Research output: Contribution to journalReviewResearchpeer-review

  2. Acupuncture for chronic hepatitis B

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The aim of this study was to perform a meta-analysis of controlled clinical trials of glucocorticoid treatment in clinical alcoholic hepatitis, adjusting for prognostic variables and their possible interaction with therapy, because these trials have given appreciably different results. Weighted logistic regression analysis was applied using the summarised descriptive data (for example, % with encephalopathy, mean bilirubin value) of the treatment and control groups of 12 controlled trials that gave this information. Despite evidence of publication bias favouring glucocorticoid treatment, its overall effect on mortality was not statistically significant (p = 0.20)--the relative risk (steroid/control) was 0.78 (95% confidence intervals 0.51, 1.18). There was indication of interaction between glucocorticoid therapy and gender, but not encephalopathy. Thus, the effect of glucocorticoid treatment may be different (beneficial or harmful) in special patient subgroups. These results do not support the routine use of glucocorticoids in patients with alcoholic hepatitis, including those with encephalopathy. Whether other subgroups may benefit needs further investigation using the individual patient data from the published trials and testing in new randomised trials.
Original languageEnglish
JournalGut
Volume37
Issue number1
Pages (from-to)113-8
Number of pages6
ISSN0017-5749
DOIs
Publication statusPublished - Jul 1995

    Research areas

  • Bilirubin, Controlled Clinical Trials as Topic, Female, Glucocorticoids, Hepatic Encephalopathy, Hepatitis, Alcoholic, Humans, Logistic Models, Male, Publication Bias, Randomized Controlled Trials as Topic, Risk Assessment, Sex Factors, Survival Analysis, Treatment Outcome

ID: 38926410